ICU Medical Inc.

175.26+0.7200+0.41%Vol 269.38K1Y Perf -10.71%
May 13th, 2022 16:00 DELAYED
BID168.04 ASK197.80
Open174.96 Previous Close174.54
Pre-Market- After-Market-
 - -%  - -
Target Price
250.00 
Analyst Rating
Strong Buy 1.50
Potential %
42.65 
Finscreener Ranking
★★+     46.75
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★     50.50
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★     58.68
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
6.80 
Earnings Rating
Sell
Market Cap4.19B 
Earnings Date
9th May 2022
Alpha0.00 Standard Deviation0.08
Beta0.48 

Today's Price Range

174.12180.50

52W Range

167.47282.00

5 Year PE Ratio Range

33.60193.80

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-15.03%
1 Month
-21.60%
3 Months
-20.39%
6 Months
-28.06%
1 Year
-10.71%
3 Years
-22.93%
5 Years
6.83%
10 Years
226.92%

TickerPriceChg.Chg.%
ICUI175.260.72000.41
AAPL147.114.55003.19
GOOG2 330.3167.09002.96
MSFT261.125.77002.26
XOM88.862.56002.97
WFC42.640.83001.99
JNJ176.85-1.0200-0.57
FB198.627.38003.86
GE75.051.77002.42
JPM119.091.05000.89
Earnings HistoryEstimateReportedSurprise %
Q01 20221.531.32-13.73
Q04 20211.411.527.80
Q03 20211.571.7712.74
Q02 20211.431.579.79
Q01 20211.321.341.52
Q04 20201.291.5217.83
Q03 20201.101.6146.36
Q02 20201.021.4542.16
Earnings Per EndEstimateRevision %Trend
3/2022 QR1.53-8.93Negative
6/2022 QR2.001.52Positive
12/2022 FY8.615.64Positive
12/2023 FY10.29-11.06Negative
Next Report Date-
Estimated EPS Next Report1.53
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume269.38K
Shares Outstanding23.90K
Shares Float17.40M
Trades Count7.38K
Dollar Volume47.59M
Avg. Volume327.87K
Avg. Weekly Volume517.96K
Avg. Monthly Volume232.29K
Avg. Quarterly Volume233.37K

ICU Medical Inc. (NASDAQ: ICUI) stock closed at 175.26 per share at the end of the most recent trading day (a 0.41% change compared to the prior day closing price) with a volume of 269.38K shares and market capitalization of 4.19B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 8000 people. ICU Medical Inc. CEO is Vivek Jain.

The one-year performance of ICU Medical Inc. stock is -10.71%, while year-to-date (YTD) performance is -26.16%. ICUI stock has a five-year performance of 6.83%. Its 52-week range is between 167.47 and 282, which gives ICUI stock a 52-week price range ratio of 6.80%

ICU Medical Inc. currently has a PE ratio of 43.50, a price-to-book (PB) ratio of 3.05, a price-to-sale (PS) ratio of 4.81, a price to cashflow ratio of 16.80, a PEG ratio of 2.32, a ROA of 5.86%, a ROC of 6.46% and a ROE of 6.84%. The company’s profit margin is 7.95%, its EBITDA margin is 16.20%, and its revenue ttm is $998.26 Million , which makes it $41.80 revenue per share.

Of the last four earnings reports from ICU Medical Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.53 for the next earnings report. ICU Medical Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for ICU Medical Inc. is Strong Buy (1.5), with a target price of $250, which is +42.65% compared to the current price. The earnings rating for ICU Medical Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ICU Medical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ICU Medical Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.67, ATR14 : 9.20, CCI20 : -160.41, Chaikin Money Flow : 0.00, MACD : -11.63, Money Flow Index : 25.60, ROC : -17.45, RSI : 25.22, STOCH (14,3) : 14.86, STOCH RSI : 0.11, UO : 39.45, Williams %R : -85.14), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ICU Medical Inc. in the last 12-months were: Brian Bonnell (Sold 0 shares of value $0 ), Christian Voigtlander (Sold 0 shares of value $0 ), Daniel Woolson (Option Excercise at a value of $0), David C. Greenberg (Sold 0 shares of value $0 ), David F. Hoffmeister (Sold 0 shares of value $0 ), Donald M. Abbey (Sold 0 shares of value $0 ), Elisha W. Finney (Sold 0 shares of value $0 ), Elisha W. Finney (Sold 2 641 shares of value $624 101 ), George A. Lopez (Option Excercise at a value of $711 676), Kevin J. McGrody (Sold 0 shares of value $0 ), Kolleen T. Kennedy (Sold 0 shares of value $0 ), Laurie Hernandez (Sold 0 shares of value $0 ), Robert S. Swinney (Option Excercise at a value of $65 430), Robert S. Swinney (Sold 6 657 shares of value $1 437 945 ), Virginia Ruth Sanzone (Option Excercise at a value of $0), Virginia Ruth Sanzone (Sold 1 550 shares of value $331 411 ), Vivek Jain (Option Excercise at a value of $1 410 960), Vivek Jain (Sold 24 000 shares of value $5 760 057 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Buy
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.50

ICU Medical Inc.

ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICU's acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding either the largest or second largest market share position in all its reporting segments: Infusion consumables (#1 market share, 40% of companywide revenue), IV solutions (#2 market share behind Baxter, 24% of companywide revenue), Infusion systems (#2 market share behind Becton Dickson, 32% of companywide revenue), and Critical care (4% of companywide revenue). The combined entity remains primarily U.S. focused, generating roughly 75% of its sales domestically.

CEO: Vivek Jain

Telephone: +1 949 366-2183

Address: 951 Calle Amanecer, San Clemente 92673, CA, US

Number of employees: 8 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

58%42%

Bearish Bullish

53%47%

News

Stocktwits